§360bb. Designation of drugs for rare diseases or conditions — Lineage
21 U.S.C. § 360bb
How 21 U.S.C. § 360bb came to say what it says — from its enactment, through every amendment and release point, to the regulations that draw authority from it.
How this provision came to be
-
Nov 21, 1997 Amendment Pub. L. 105–115 — Food and Drug Administration Modernization Act of 1997 See what changed
-
Apr 18, 1988 Amendment Pub. L. 100–290 — Orphan Drug Amendments of 1988
-
Aug 15, 1985 Amendment Pub. L. 99–91 — Orphan Drug Amendments of 1985
-
Oct 30, 1984 Amendment Pub. L. 98–551 — Health Promotion and Disease Prevention Amendments of 1984
-
Jan 4, 1983 Enacted Pub. L. 97–414 — Orphan Drug Act
Release history
8 of 402 release points changed the text.
-
reading now Public Law 119-102
-
91 release points — no change to the text
-
Public Law 117-224 Text changed See what changed
-
33 release points — no change to the text
-
Public Law 117-79, except 58 Text changed See what changed
-
7 release points — no change to the text
-
Public Law 117-57 Text changed See what changed
-
50 release points — no change to the text
-
Public Law 116-138, except 113 Text changed See what changed
-
130 release points — no change to the text
-
Public Law 114-146 Text changed See what changed
-
65 release points — no change to the text
-
Public Law 113-21 Text changed See what changed
-
15 release points — no change to the text
-
2 release points — no change to the text
-
Jan 4, 1995 Public Law 103-465 Text changed
Derived authority
Named as rulemaking authority in 6 regulations.
-
Jan 1, 1985 Effective Date of 1985 Amendment inferred